Insperity
- Market cap
- 1.84B
- P/E (TTM)i
- -109.61
- P/Bi
- 30.20
- EPSi
- -0.19
- Div yieldi
- 4.98%
- 52W posi
- 81%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 113.16% -0.08pp
- Institutions
- 324 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 40 buys · 10 sells
| Name | Role | Stake |
|---|---|---|
| Paul Sarvadi | Chairperson & CEO | 4.47% |
| Richard Rawson | Director | 0.61% |
| Arthur A. Arizpe | President | 0.45% |
| James Allison | Executive VP of Comprehensive Benefits Solutions & Chief Profitability Officer | 0.17% |
| Carol Kaufman | Independent Director | 0.12% |
| Randall Mehl | Independent Director | 0.07% |
| Timothy Clifford | Lead Independent Director | 0.06% |
| Ellen Masterson | Independent Director | 0.05% |
| John Lumelleau | Independent Director | 0.05% |
| Latha Ramchand | Independent Director | 0.04% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-10 | Paul Sarvadi | Chairperson & CEO | Other Disposition | -7,500 | -- |
| 2026-08-16 | Paul Sarvadi | Chairperson & CEO | Other Disposition | -30,000 | -- |
| 2026-06-02 | Paul Sarvadi | Chairperson & CEO | Open Market Acquisition | +233,000 | $34.05 |
| 2026-05-17 | W. Wilmington | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Richard Rawson | Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Carol Kaufman | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | John Morphy | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Timothy Clifford | Lead Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | John Lumelleau | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Eli Jones | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Randall Mehl | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Ellen Masterson | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-17 | Latha Ramchand | Independent Director | Other Acquisition | +6,201 | -- |
| 2026-05-04 | Paul Sarvadi | Chairperson & CEO | Open Market Acquisition | +100,000 | $28.20–30.00 |
| 2026-03-18 | Paul Sarvadi | Chairperson & CEO | Open Market Acquisition | +201,987 | $22.53–23.93 |
| 2026-03-10 | Christian Callens | Senior VP of Legal, General Counsel & Secretary | Open Market Acquisition | +1,250 | $19.28 |
| 2026-03-10 | Ellen Masterson | Independent Director | Open Market Acquisition | +1,200 | $19.90 |
| 2026-03-09 | James Allison | Executive VP of Comprehensive Benefits Solutions & Chief Profitability Officer | Open Market Acquisition | +10,000 | $20.45 |
| 2026-03-02 | Paul Sarvadi | Chairperson & CEO | Sale to Issuer | -11,272 | $21.13–22.21 |
| 2026-03-02 | Paul Sarvadi | Chairperson & CEO | Other Acquisition | +2,944 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.